Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


13.02.2017

2 BMC Neurol
4 J Neural Transm (Vienna)
2 JAMA
1 Mov Disord
1 Neurochem Res
3 Neurology
1 Neurosci Lett
4 PLoS One
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. LEAVY B, Kwak L, Hagstromer M, Franzen E, et al
    Evaluation and implementation of highly challenging balance training in clinical practice for people with Parkinson's disease: protocol for the HiBalance effectiveness-implementation trial.
    BMC Neurol. 2017;17:27.
    PubMed     Text format     Abstract available

  2. ZHANG J, Xu CY, Liu J
    Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease.
    BMC Neurol. 2017;17:23.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  3. LINGOR P, Carboni E, Koch JC
    Alpha-synuclein and iron: two keys unlocking Parkinson's disease.
    J Neural Transm (Vienna). 2017 Feb 6. doi: 10.1007/s00702-017-1695.
    PubMed     Text format     Abstract available

  4. RUSS K, Flores J, Brudek T, Doudet DJ, et al
    Differential behavioral outcomes following neonatal versus fetal human retinal pigment epithelial cell striatal implants in parkinsonian rats.
    J Neural Transm (Vienna). 2017 Feb 4. doi: 10.1007/s00702-017-1683.
    PubMed     Text format     Abstract available

  5. HATANO T, Okuzumi A, Kamagata K, Daida K, et al
    Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.
    J Neural Transm (Vienna). 2017 Feb 3. doi: 10.1007/s00702-017-1688.
    PubMed     Text format     Abstract available

  6. KLINGELHOEFER L, Reichmann H
    Parkinson's disease as a multisystem disorder.
    J Neural Transm (Vienna). 2017 Feb 2. doi: 10.1007/s00702-017-1692.
    PubMed     Text format     Abstract available


    JAMA

  7. HAMPTON T
    Drug Under Study for Diabetes a Potential Parkinson Therapy.
    JAMA. 2017;317:465.
    PubMed     Text format    

  8. GREEN MJ, Czerwiec MK
    Graphic Medicine: The Best of 2016.
    JAMA. 2016;316:2580-2581.
    PubMed     Text format    


    Mov Disord

  9. GALLEA C, Ewenczyk C, Degos B, Welter ML, et al
    Pedunculopontine network dysfunction in Parkinson's disease with postural control and sleep disorders.
    Mov Disord. 2017 Feb 6. doi: 10.1002/mds.26923.
    PubMed     Text format     Abstract available


    Neurochem Res

  10. NATARAJ J, Manivasagam T, Justin Thenmozhi A, Essa MM, et al
    Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3beta and mTOR Signalling
    Neurochem Res. 2017 Feb 8. doi: 10.1007/s11064-017-2183.
    PubMed     Text format     Abstract available


    Neurology

  11. LEWITT PA, Li J, Lu M, Guo L, et al
    Metabolomic biomarkers as strong correlates of Parkinson disease progression.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003663.
    PubMed     Text format     Abstract available

  12. ALVES G, Bonanni L
    Neurofilament light: A heavyweight diagnostic biomarker in neurodegenerative parkinsonism?
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003699.
    PubMed     Text format    

  13. HANSSON O, Janelidze S, Hall S, Magdalinou N, et al
    Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
    Neurology. 2017 Feb 8. pii: 10.1212/WNL.0000000000003680.
    PubMed     Text format     Abstract available


    Neurosci Lett

  14. TIAN S, Yang X, Zhao Q, Zheng J, et al
    Association between a heme oxygenase-2 genetic variant and risk of Parkinson's disease in Han Chinese.
    Neurosci Lett. 2017 Feb 5. pii: S0304-3940(17)30114.
    PubMed     Text format     Abstract available


    PLoS One

  15. PAUL R, Choudhury A, Kumar S, Giri A, et al
    Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    PLoS One. 2017;12:e0171285.
    PubMed     Text format     Abstract available

  16. ZEISS CJ, Allore HG, Beck AP
    Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease.
    PLoS One. 2017;12:e0171790.
    PubMed     Text format     Abstract available

  17. STOTT SR, Hayat S, Carnwath T, Garas S, et al
    CD24 expression does not affect dopamine neuronal survival in a mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0171748.
    PubMed     Text format     Abstract available

  18. CIESIELSKA A, Samaranch L, San Sebastian W, Dickson DW, et al
    Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial.
    PLoS One. 2017;12:e0169965.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  19. RUGGERI J, Mariani LL, Aix S, Bonnet AM, et al
    "De-novo" consultation: Evaluation of an outpatient's clinic dedicated to early diagnosis of parkinsonian syndromes.
    Rev Neurol (Paris). 2017 Jan 31. pii: S0035-3787(16)30163.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: